| Shannon Deprado, | |
|
40487 Banshee Dr, Leesburg, VA 20175-7503 | |
| (703) 850-5301 | |
| Not Available |
| Full Name | Shannon Deprado |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 40487 Banshee Dr, Leesburg, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306222609 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2202004233 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shannon Deprado, 40487 Banshee Dr, Leesburg, VA 20175-7503 Ph: (703) 779-4926 | Shannon Deprado, 40487 Banshee Dr, Leesburg, VA 20175-7503 Ph: (703) 850-5301 |
News Archive
CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today results from a multi-center, community-based patient registry, the PRESET Registry, evaluating the use of the Corus CAD test in patients with symptoms suggestive of obstructive coronary artery disease (CAD) in the primary care setting.
When Americans engage in health-smart habits such as participating in health coaching and disease management programs, substituting generic medications for brand name drugs and avoiding unnecessary trips to the emergency room, their total medical costs went down 15 percent - an average $358 per person in the first year - according to a new multi-year study comparing the health care claims experience of 897,000 CIGNA customers in consumer driven health (CDH) plans, PPOs and HMOs.
Results from a study looking at an experimental drug to tackle the debilitating side effect of dyskinesia, have offered hope that it may have potential as a future treatment for people with Parkinson's.
In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.
Lancet Infectious Diseases Newsdesk examines how despite evidence that a new therapy to treat sleeping sickness, called nifurtimox—eflornithine (NECT) is a step forward in treating the disease, it has yet to be implemented by countries "13 months after data from a successful trial was presented." The main issue at hand - "nifurtimox is not registered for use in sleeping sickness," the journal writes. The article also examines other factors complicating the implementation of the therapy (Morris, 12/09).
› Verified 6 days ago
Tara Leigh Willis, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 603 Buchanan Ct Se, Leesburg, VA 20175 Phone: 703-431-1499 | |
Ms. Mary Shannon Bonk, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 43618 Carradoc Farm Ter, Leesburg, VA 20176 Phone: 571-333-3811 Fax: 571-333-3811 | |
Margie Comerford, SLP, CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 44035 Riverside Pkwy, Suie 500a, Leesburg, VA 20176 Phone: 703-858-6667 Fax: 703-858-6665 | |
Mrs. Rachel Z Marvin, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40989 Grenata Preserve Pl, Leesburg, VA 20175 Phone: 443-765-7151 | |
Alaina Marie Gotwalt, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 43850 Heatherstone Terrace, Unit 406, Leesburg, VA 20176 Phone: 717-383-1810 | |
Lmg Speech Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19450 Deerfield Avenue, Suite 300, Leesburg, VA 20176 Phone: 571-707-2067 Fax: 571-209-1870 | |
Barbara Hollar Madgwick, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20 Union St Nw, Leesburg, VA 20176 Phone: 571-252-2184 |